Pancreatic Cancer Research

ResearcherThe Cancer Institute HospitalNo recent work listed

Masashi Sawada

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper

Papers 1

  1. Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer. Co-author DOI 10.1186/s12885-020-06945-8↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takashi Sasaki · 1 shared paper, 2020 · strength 0.10
  2. Tsuyoshi Takeda · 1 shared paper, 2020 · strength 0.10
  3. Akiyoshi Kasuga · 1 shared paper, 2020 · strength 0.10
  4. Masato Ozaka · 1 shared paper, 2020 · strength 0.10
  5. Takafumi Mie · 1 shared paper, 2020 · strength 0.10
  6. Yuto Yamada · 1 shared paper, 2020 · strength 0.10
  7. Takaaki Furukawa · 1 shared paper, 2020 · strength 0.10
  8. Masato Matsuyama · 1 shared paper, 2020 · strength 0.10
  9. Naoki Sasahira · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.